Ascend Therapeutics - Company & Market Research Reports

Ascend Therapeutics is a biopharmaceutical company, develops and commercializes pharmaceutical transdermal therapies for the treatment of chronic health conditions in the United States. Its products include afimoxifene gel, an antiestrogen for the treatment of cyclic breast pain and other estrogen dependent disorders in premenopausal women. It also offers transdermal dihydrotestosterone gel therapy for late-onset hypogonadism. The company was incorporated in 2001 and is headquartered in Herndon, Virginia.


EstroGel 2016 U.S Promotional Report - Product Thumbnail Image

EstroGel 2016 U.S Promotional Report

  • Report
  • 17 Pages
From
Dendrimers and Polymer Drug Conjugates Market, 2016 - 2026 - Product Thumbnail Image

Dendrimers and Polymer Drug Conjugates Market, 2016 - 2026

  • Report
  • 183 Pages
From
Guide to U.S. Specialty Pharmaceutical Market: Companies, Products and Market Data - Product Thumbnail Image

Guide to U.S. Specialty Pharmaceutical Market: Companies, Products and Market Data

  • Report
  • 203 Pages
From
Ascend Therapeutics, Inc Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis - Product Thumbnail Image

Ascend Therapeutics, Inc Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

  • Company Profile
  • 30 Pages
From
  • 4 Results (Page 1 of 1)
Loading Indicator
adroll